These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

278 related items for PubMed ID: 26019984

  • 1. Impact of TET2, SRSF2, ASXL1 and SETBP1 mutations on survival of patients with chronic myelomonocytic leukemia.
    Cui Y, Tong H, Du X, Li B, Gale RP, Qin T, Liu J, Xu Z, Zhang Y, Huang G, Jin J, Fang L, Zhang H, Pan L, Hu N, Qu S, Xiao Z.
    Exp Hematol Oncol; 2015; 4():14. PubMed ID: 26019984
    [Abstract] [Full Text] [Related]

  • 2. TET2 mutations were predictive of inferior prognosis in the presence of ASXL1 mutations in patients with chronic myelomonocytic leukemia.
    Cui Y, Tong H, Du X, Li B, Gale RP, Qin T, Liu J, Xu Z, Zhang Y, Huang G, Jin J, Fang L, Zhang H, Pan L, Hu N, Qu S, Xiao Z.
    Stem Cell Investig; 2016; 3():50. PubMed ID: 27777939
    [Abstract] [Full Text] [Related]

  • 3. Prognostic interaction between ASXL1 and TET2 mutations in chronic myelomonocytic leukemia.
    Patnaik MM, Lasho TL, Vijayvargiya P, Finke CM, Hanson CA, Ketterling RP, Gangat N, Tefferi A.
    Blood Cancer J; 2016 Jan 15; 6(1):e385. PubMed ID: 26771811
    [Abstract] [Full Text] [Related]

  • 4. ASXL1 and SETBP1 mutations and their prognostic contribution in chronic myelomonocytic leukemia: a two-center study of 466 patients.
    Patnaik MM, Itzykson R, Lasho TL, Kosmider O, Finke CM, Hanson CA, Knudson RA, Ketterling RP, Tefferi A, Solary E.
    Leukemia; 2014 Nov 15; 28(11):2206-12. PubMed ID: 24695057
    [Abstract] [Full Text] [Related]

  • 5. [Molecular features of 109 patients with chronic myelomonocytic leukemia in a single center].
    Qu SQ, Pan LJ, Qin TJ, Xu ZF, Li B, Wang HJ, Sun Q, Jia YJ, Li CW, Cai WY, Gao QY, Jiao M, Xiao ZJ.
    Zhonghua Xue Ye Xue Za Zhi; 2023 May 14; 44(5):373-379. PubMed ID: 37550186
    [Abstract] [Full Text] [Related]

  • 6. Myeloid neoplasms with isolated isochromosome 17q demonstrate a high frequency of mutations in SETBP1, SRSF2, ASXL1 and NRAS.
    Kanagal-Shamanna R, Luthra R, Yin CC, Patel KP, Takahashi K, Lu X, Lee J, Zhao C, Stingo F, Zuo Z, Routbort MJ, Singh RR, Fox P, Ravandi F, Garcia-Manero G, Medeiros LJ, Bueso-Ramos CE.
    Oncotarget; 2016 Mar 22; 7(12):14251-8. PubMed ID: 26883102
    [Abstract] [Full Text] [Related]

  • 7. Mutational landscape of chronic myelomonocytic leukemia in Chinese patients.
    Nie Y, Shao L, Zhang H, He CK, Li H, Zou J, Chen L, Ji H, Tan H, Lin Y, Ru K.
    Exp Hematol Oncol; 2022 May 24; 11(1):32. PubMed ID: 35610628
    [Abstract] [Full Text] [Related]

  • 8. The prognostic value of the interaction between ASXL1 and TET2 gene mutations in patients with chronic myelomonocytic leukemia: a meta-analysis.
    Zhao W, Zhang C, Li Y, Li Y, Liu Y, Sun X, Liu M, Shao R.
    Hematology; 2022 Dec 24; 27(1):367-378. PubMed ID: 35306971
    [Abstract] [Full Text] [Related]

  • 9. Poor Prognostic Implication of ASXL1 Mutations in Korean Patients With Chronic Myelomonocytic Leukemia.
    Kim HY, Lee KO, Park S, Jang JH, Jung CW, Kim SH, Kim HJ.
    Ann Lab Med; 2018 Nov 24; 38(6):495-502. PubMed ID: 30027691
    [Abstract] [Full Text] [Related]

  • 10. Prognostic significance of ASXL1 mutations in myelodysplastic syndromes and chronic myelomonocytic leukemia: A meta-analysis.
    Lin Y, Zheng Y, Wang ZC, Wang SY.
    Hematology; 2016 Sep 24; 21(8):454-61. PubMed ID: 27077763
    [Abstract] [Full Text] [Related]

  • 11. Clinical significance of CSF3R, SRSF2 and SETBP1 mutations in chronic neutrophilic leukemia and chronic myelomonocytic leukemia.
    Ouyang Y, Qiao C, Chen Y, Zhang SJ.
    Oncotarget; 2017 Mar 28; 8(13):20834-20841. PubMed ID: 28209919
    [Abstract] [Full Text] [Related]

  • 12. CSF3R T618I, SETBP1 G870S, SRSF2 P95H, and ASXL1 Q780* tetramutation co-contribute to myeloblast transformation in a chronic neutrophilic leukemia.
    Qian Y, Chen Y, Li X.
    Ann Hematol; 2021 Jun 28; 100(6):1459-1461. PubMed ID: 33822276
    [Abstract] [Full Text] [Related]

  • 13. Prognostic score including gene mutations in chronic myelomonocytic leukemia.
    Itzykson R, Kosmider O, Renneville A, Gelsi-Boyer V, Meggendorfer M, Morabito M, Berthon C, Adès L, Fenaux P, Beyne-Rauzy O, Vey N, Braun T, Haferlach T, Dreyfus F, Cross NC, Preudhomme C, Bernard OA, Fontenay M, Vainchenker W, Schnittger S, Birnbaum D, Droin N, Solary E.
    J Clin Oncol; 2013 Jul 01; 31(19):2428-36. PubMed ID: 23690417
    [Abstract] [Full Text] [Related]

  • 14. Chronic Myelomonocytic Leukemia: a Genetic and Clinical Update.
    McCullough KB, Patnaik MM.
    Curr Hematol Malig Rep; 2015 Sep 01; 10(3):292-302. PubMed ID: 26122388
    [Abstract] [Full Text] [Related]

  • 15. Chronic Myelomonocytic Leukemia: Focus on Clinical Practice.
    Patnaik MM, Tefferi A.
    Mayo Clin Proc; 2016 Feb 01; 91(2):259-72. PubMed ID: 26848006
    [Abstract] [Full Text] [Related]

  • 16. Mutations in chronic myelomonocytic leukemia and their prognostic relevance.
    Jian J, Qiao Y, Li Y, Guo Y, Ma H, Liu B.
    Clin Transl Oncol; 2021 Sep 01; 23(9):1731-1742. PubMed ID: 33861431
    [Abstract] [Full Text] [Related]

  • 17. Chronic myelomonocytic leukemia: 2024 update on diagnosis, risk stratification and management.
    Patnaik MM, Tefferi A.
    Am J Hematol; 2024 Jun 01; 99(6):1142-1165. PubMed ID: 38450850
    [Abstract] [Full Text] [Related]

  • 18. DNMT3A mutations are associated with inferior overall and leukemia-free survival in chronic myelomonocytic leukemia.
    Patnaik MM, Barraco D, Lasho TL, Finke CM, Hanson CA, Ketterling RP, Gangat N, Tefferi A.
    Am J Hematol; 2017 Jan 01; 92(1):56-61. PubMed ID: 27733013
    [Abstract] [Full Text] [Related]

  • 19. Chronic Myelomonocytic leukemia: 2020 update on diagnosis, risk stratification and management.
    Patnaik MM, Tefferi A.
    Am J Hematol; 2020 Jan 01; 95(1):97-115. PubMed ID: 31736132
    [Abstract] [Full Text] [Related]

  • 20. Chronic myelomonocytic leukemia: 2018 update on diagnosis, risk stratification and management.
    Patnaik MM, Tefferi A.
    Am J Hematol; 2018 Jun 01; 93(6):824-840. PubMed ID: 29878489
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.